Carregant...
Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19
A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is the cause of coronavirus disease 2019 (COVID-19). It emerged in China in 2019 and has since spread worldwide. COVID-19 has a wide spectrum of clinical scenarios, ranging from totally asymptomatic to death. Preventi...
Guardat en:
| Publicat a: | Int J Infect Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7816887/ https://ncbi.nlm.nih.gov/pubmed/33476760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2021.01.035 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|